
The use of zzso zzso either alone or in combination with zzso killer cells, tumor zzso zzso or other zzso agents has added a new list of alternatives to conventional zzso zzso Little information is available about the zzso changes occurring in patients treated with these zzso In this study, we reviewed the zzso materials from 19 patients, 12 men and 7 women, with a variety of zzso including melanoma, zzso cell zzso gastrointestinal and pulmonary zzso and zzso zzso who died after receiving zzso zzso Death occurred at intervals ranging from less than 1 hour to 143 days following the last dose of zzso All patients dying at or less than 43 days following zzso of therapy had zzso infiltrates of varying intensity in residual zzso At zzso the major cause of death unrelated to the presence of zzso tumor was bacterial zzso In addition, we found evidence of significant cardiac and pulmonary zzso two patients with acute zzso zzso one with and one without significant coronary artery disease, two cases of unexplained zzso zzso and one case of fatal pulmonary zzso plugging following an infusion of zzso killer zzso Thus, not unlike other forms of therapy for cancer, zzso zzso does not appear to be without significant zzso 

